您的位置:首页 > 医药代理医药代理
高敏肌钙蛋白检测并不能改善急性心梗患者的预后
MIMS医药资讯2020-04-09 09:10:32人已围观
The use of high-sensitivity cardiactroponin assays was not associated with a lower subsequent incidence of myocardial infarction (MI) or cardiovascular death at 1 year, according to results of the High-STEACS trial reported at ESC 2018.
In the study among 48,282 patients (meanage, 61 years; 47 percent women) performed between June 2013 and March 2016,the high-sensitivity cardiac troponin I assay reclassified 17 percent ofpatients with MI or myocardial injury who were not identified by the contemporary assay. [N Engl J Med 2018;doi: 10.1016/ S0140-6736(18)31996-2].
Among those reclassified, subsequent MI or cardiovascular death within 1 year occurred in 15 percent of patients in the validation phase vs. 12 percent in the implementation phase (odds ratio [OR], 1.10,95 percent confidence interval [CI], 0.75 to 1.61; P=0.620).
The validation phase was done for 6-12months with contemporary cardiac troponin I assay used as a guide for care. The subsequent implementation phase [early (n=5 hospitals) or late (n=5 hospitals)]involved testing patients with the high-sensitivity cardiac troponin I assay immediately or 6 months after the validation phase.
In the reclassified patients, there were also no differences in any secondary efficacy and safety outcome measuresbetween the validation and implementation phases, including all cause death (OR,0.71, 95 percent CI, 0.46 to 1.10), hospitalization for heart failure (OR,1.34, 95 percent CI, 0.84 to 2.16) and ischaemic stroke (OR, 0.85, 95 percent CI, 0.33 to 2.18).
“The trial found that implementation of a high-sensitivity cardiac troponin I assay using the 99th centile as the diagnostic threshold increased the frequency of diagnosing MI. However, use of this method to help diagnose and treat patients was not associated with lower rates of recurrent MI or cardiovascular death in 1 year,” said investigator Professor Nicholas Mills from the University of Edinburgh, UK.
“Among those reclassified, around one-third was diagnosed with type I MI, where treatment guidelines are still lacking.Also, a majority of the reclassifyed patients were females, where the effectiveness of treatment modalities has not been tested widely,” Mills further commented.
“In the study, sampling and treatment protocols were not according to ESC guidelines, and patients with renal failure, myocarditis, and type 2 MI were included. These probably resulted in ‘dilution’ of outcome results,”said discussant Professor Christian Hamm from the University of Glessen, Germany.
The High-STEACS trial is the first randomized trial to evaluate whether the introduction of a high-sensitivity cardiac troponin I assay with a 99th centile diagnostic threshold would reduce subsequent MI or cardiovascular death at 1 year among patients suspected to have acute coronary syndrome. According to the universal definition of MI, any increase in cardiac troponin above the 99th centile of a healthy reference population should be used as one of the diagnostic criteria for MI. [Eur Heart J 2018, doi: 10.1093/eurheartj/ehy462].
欲知更多医药信息,请登录MIMS.com
免费下载MIMS应用程序!
很赞哦! ()
相关文章
- 医药招商保健食品降糖:网络药店行业不断升温发展稳健
- 药品招商与药品销售的区别:CFDA下令:停止进口4个药品!
- 南阳药品代理招商网:零售药店眼科用药企业TOP10,榜首年销8.4亿
- 筛选药品代理商:重磅品种首仿“卡位赛” 正大天晴“赢了”
- 郑州高新区招聘医药代理:医疗器械行业爆发了,18家销售过10亿!
- 雾化药品招商网:佛慈制药为中成药出口打“基础”
- 资阳生物医药科技园招商引资:安柯信银离子烧烫伤抗菌敷料 防止烧烫伤伤口感
- 医药代理商的功能:和记黄埔医药呋喹替尼III期临床试验成功
- 药品代理价格制定:陕西医用耗材两票制 内部已经定稿了!
- 药品名企招商:17亿大品种又一家药企过评 “博弈”战开始
- 医药公司招商经理职责:研究发现:ANO7基因在改善前列腺癌患者的诊断上扮演着关
- 临床药品招商网独家品种:五味子糖浆 益气补肾 镇静安神
- 浙江省优秀的医药代理公司:哈药股份遭遇退货 业务损失谁负责
- 医药招商部管理制度:大利好!FDA为抑郁症辅助药开辟绿色通道
- 药品招商底价大包方案:今年将完成11000件化药创新药临床试验申请
- 商丘医药代理招聘:减肥血泪史全文 减肥需要付出哪些行动_减肥健身_医药新闻_
- 评估医药代理商:医药代理商如何精细化管理(上)
- 医药招商经理简历:大势已定!医用耗材“零差率”风暴席卷各地
- 医药绿色疗法招商信息:生意宝启动数据战略 发布国内首个大宗商品指数
- 医药代理广东:哈尔滨加强防控甲型H1N1流感药械监管
- 独家妇科药品招商:中药企业不具提取能力2016年关门
- 桂林医药代理:全国医院大督查开始了,要查186家!
- 泰康药品代理好做吗:超级细菌引爆炒作热,国内药企澄清谣言
- 药品招商业务员:使用远红外FLS-A颈椎病要注意什么
- 华润医药代理商:国务院印发《意见》 这五个重点必须落实
- 招商医药基金0:曼新妥前列地尔注射液
- 江西康宝医药生物科技有限公司招商:惊!2016年底全面停止门诊输注抗菌药物
- 山西省医药代理商业公司招聘:加强用药保障力度 新增339种儿童药可报销
- 药品招商问题和解决方案:20家省级大医院+14市所有公立医院 组团带量采购
- 医药代理商怎么差价销售:又一常用药,全国断货
随机图文
拿钱啦!今日东方医药网瓜分10000W
东方医药招商网:wwwyaozscom-拿钱啦!今日东方医药网瓜分10000W现金活动数据出炉,明后天等你来~意大利确诊病例过万 紧急求助中
东方医药招商网:wwwyaozscom-意大利确诊病例过万 紧急求助中国【内蒙古】基药、非基药、低价药
医药资讯地方台:yiyaoguanchajia-【内蒙古】基药、非基药、低价药采购TOP 10国家重点监察5类人,医院院长、副
药代通医药资讯平台:yaodaitongnews-国家重点监察5类人,医院院长、副院长列首位已确定开展及放弃的药企数量
中国医药招商:china360com-已确定开展及放弃的药企数量「一周药闻速读」药代通带你速读
药代通医药资讯平台:yaodaitongnews-「一周药闻速读」药代通带你速读本周新鲜事儿蜂胶可以治疗糖尿病 糖友怎么吃
1168医药招商网:yiyao1168-蜂胶可以治疗糖尿病 糖友怎么吃蜂胶!国药新品,火爆退出,隆重招商,敬请关
1168医药招商网:yiyao1168-国药新品,火爆退出,隆重招商,敬请关注!【四川】9家药商被开罚单!
医药资讯地方台:yiyaoguanchajia-【四川】9家药商被开罚单!何以解忧 唯有中奖 | 药代通“最
药代通医药资讯平台:yaodaitongnews-何以解忧 唯有中奖 | 药代通“最美”药代颁奖la~芬太尼滥用责任完全在美国
药代通医药资讯平台:yaodaitongnews-芬太尼滥用责任完全在美国又一省药企大面积申请药品撤销挂
中国医药招商:china360com-又一省药企大面积申请药品撤销挂网